HomeComparePFE vs RTX

PFE vs RTX: Dividend Comparison 2026

PFE yields 6.20% · RTX yields 1.45%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PFE wins by $17.3K in total portfolio value· pulled ahead in Year 9
10 years
PFE
Pfizer Inc.
● Live price
6.20%
Share price
$27.76
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$51.1K
Annual income
$27,210.54
Full PFE calculator →
RTX
RTX
● Live price
1.45%
Share price
$187.15
Annual div
$2.72
5Y div CAGR
32.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$33.8K
Annual income
$3,684.67
Full RTX calculator →

Portfolio growth — PFE vs RTX

📍 PFE pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPFERTX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PFE + RTX cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PFE pays
RTX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PFE
Annual income on $10K today (after 15% tax)
$526.66/yr
After 10yr DRIP, annual income (after tax)
$23,128.96/yr
RTX
Annual income on $10K today (after 15% tax)
$123.54/yr
After 10yr DRIP, annual income (after tax)
$3,131.97/yr
At 15% tax rate, PFE beats the other by $19,996.99/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PFE + RTX for your $10,000?

PFE: 50%RTX: 50%
100% RTX50/50100% PFE
Portfolio after 10yr
$42.4K
Annual income
$15,447.61/yr
Blended yield
36.39%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on RTX right now

PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-0.9% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
RTX
Analyst Ratings
17
Buy
9
Hold
Consensus: Buy
Price Target
$219.20
+17.1% upside vs current
Range: $168.00 — $240.00
Altman Z
2.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PFE buys
0
RTX buys
0
No recent congressional trades found for PFE or RTX in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPFERTX
Forward yield6.20%1.45%
Annual dividend / share$1.72$2.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR13.2%32.4%
Portfolio after 10y$51.1K$33.8K
Annual income after 10y$27,210.54$3,684.67
Total dividends collected$60.1K$12.1K
Payment frequencyquarterlyquarterly
SectorHealthcareIndustrials
Analyst consensusHoldBuy
Analyst price target$27.50$219.20

Year-by-year: PFE vs RTX ($10,000, DRIP)

YearPFE PortfolioPFE Income/yrRTX PortfolioRTX Income/yrGap
1$9,161$701.38$10,892$192.43$1.7KRTX
2$8,610$859.79$11,914$259.36$3.3KRTX
3$8,366$1,081.25$13,099$351.03$4.7KRTX
4$8,483$1,405.66$14,494$477.56$6.0KRTX
5$9,084$1,907.24$16,162$653.83$7.1KRTX
6$10,418$2,732.78$18,196$902.17$7.8KRTX
7$13,007$4,193.56$20,726$1,256.79$7.7KRTX
8$18,010$7,005.87$23,948$1,771.40$5.9KRTX
9← crossover$28,216$12,979.89$28,157$2,532.66+$59.00PFE
10$51,081$27,210.54$33,813$3,684.67+$17.3KPFE

PFE vs RTX: Complete Analysis 2026

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →

RTXIndustrials

RTX Corporation, an aerospace and defense company, provides systems and services for the commercial, military, and government customers in the United States and internationally. It operates through three segments: Collins Aerospace, Pratt & Whitney, and Raytheon. The Collins Aerospace Systems segment offers aerospace and defense products, and aftermarket service solutions for civil and military aircraft manufacturers and commercial airlines, as well as regional, business, and general aviation, defense, and commercial space operations. This segment also designs, produces, and supports cabin interior, including oxygen systems, food and beverage preparation, storage and galley systems, and lavatory and wastewater management systems; battlespace, test and training range systems, crew escape systems, and simulation and training solutions; information management services; and aftermarket services that include spare parts, overhaul and repair, engineering and technical support, training and fleet management solutions, and asset and information management services. Its Pratt & Whitney segment supplies aircraft engines for commercial, military, business jet, and general aviation customers; and produces, sells, and services military and commercial auxiliary power units. The Raytheon segment provides defensive and offensive threat detection, tracking, and mitigation capabilities for U.S., foreign government, and commercial customers. The company was formerly known as Raytheon Technologies Corporation and changed its name to RTX Corporation in July 2023. RTX Corporation was incorporated in 1934 and is headquartered in Arlington, Virginia.

Full RTX Calculator →
📬

Get this PFE vs RTX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PFE vs JNJPFE vs MRKPFE vs ABBVPFE vs BMYPFE vs LLYPFE vs SCHDPFE vs JEPIPFE vs O

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.